title: [Ovocyte vitrification: a tool for the future].
abstract: Ovocyte vitrification was finally authorized by the new law voted in July 2011 upon the revision of the French bioethics law. Expected for 30 years, cryopreservation of female gametes had a major impact on Assisted Reproductive Technologies (ART) practice worldwide and in our country. It brought tremendous changes in the field of reproductive biology, from intraconjugal infertility management to gamete donation, through autologous cryopreservation for fertility preservation. Although it appears to be "obvious", ovocyte vitrification seems to be barely used as a routine technique in French IVF laboratories. We will discuss the events that led to the present situation. We will also tackle the expected benefits of ovocyte vitrification especially as an alternative to embryo freezing.
authors.forename: Pierre
authors.initials: P
authors.lastname: Boyer
authors.forename: Debbie
authors.initials: D
authors.lastname: Montjean
authors.forename: Cendrine
authors.initials: C
authors.lastname: Siraudin
authors.forename: Marie
authors.initials: M
authors.lastname: Gervoise-Boyer
mesh_terms: D015925:Cryopreservation / Q000379:methods; D019924:Embryo Disposition; D004624:Embryo Transfer; D005260:Female; D059247:Fertility Preservation; D005307:Fertilization in Vitro; D005602:France; D006801:Humans; D007247:Infertility, Female; D009042:Motivation; D018587:Oocyte Donation; D054315:Oocyte Retrieval; D009865:Oocytes / Q000166:cytology; D027724:Reproductive Techniques, Assisted / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D014021:Tissue Preservation / Q000191:economics / Q000379:methods* / Q000706:statistics & numerical data; D058989:Vitrification